THRIVE ANIMAL HEALTH
Dead / Abandoned — Abandoned — failure to respond (as of 16 Oct 2024)
What this means for you
This application is over — abandoned 03 Oct 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97931706
- Mark type
- Design + words
- Filed
- 11 May 2023
- Abandoned
- 03 Oct 2024
- Attorney of record
- Joseph A. Sebollt
Goods and services
- Class 005 — Pharmaceuticals: ANIMAL FEED ADDITIVE FOR USE AS A NUTRITIONAL SUPPLEMENT FOR MEDICAL PURPOSES; ANIMAL FEED SUPPLEMENTS; DIETARY SUPPLEMENTS AND NUTRITIONAL SUPPLEMENTS FOR ANIMAL FEED SUPPLEMENTS; NON-MEDICATED ADDITIVES FOR ANIMAL FEED FOR USE AS NUTRITIONAL SUPPLEMENTS; NUTRACEUTICALS FOR USE AS A DIETARY SUPPLEMENT IN ANIMALS; VITAMINS AND DIETARY FOOD SUPPLEMENTS FOR ANIMALS
- Class 040 — Treatment of materials: CONTRACT MANUFACTURING IN THE FIELD OF EQUINE FEED ADDITIVE FOR USE AS A NUTRITIONAL SUPPLEMENT FOR MEDICAL PURPOSES, EQUINE FEED SUPPLEMENTS, DIETARY SUPPLEMENTS AND NUTRITIONAL SUPPLEMENTS FOR HORSES, FEED SUPPLEMENTS FOR HORSES AND NUTRITIONAL SUPPLEMENTS, NUTRACEUTICALS FOR USE AS A DIETARY SUPPLEMENT IN HORSES AND VITAMINS AND DIETARY FOOD SUPPLEMENTS FOR HORSES
Owner
- Biological Prospects, LLC, Lexington, KY, US
Prosecution history
- 16 Oct 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 16 Oct 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 02 Jul 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 02 Jul 2024 — FINAL REFUSAL E-MAILED
- 02 Jul 2024 — FINAL REFUSAL WRITTEN
- 15 Dec 2023 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 15 Dec 2023 — LETTER OF SUSPENSION E-MAILED
- 15 Dec 2023 — SUSPENSION LETTER WRITTEN
- 14 Dec 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Dec 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Dec 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Sept 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Sept 2023 — NON-FINAL ACTION E-MAILED
- 28 Sept 2023 — NON-FINAL ACTION WRITTEN
- 28 Sept 2023 — ASSIGNED TO EXAMINER